Nasus Pharma CEO Issues 2025 Letter to Shareholders
We received from Nasus Pharma Ltd ( NYSE: NSRX) and we are glad to publish the following press release: "Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", “Nasus” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today issued a…